{"title":"使用 0.3% 罗氟司特局部乳膏成功治疗海利-海利病的病例报告","authors":"Klepper Em","doi":"10.46889/jdr.2024.5103","DOIUrl":null,"url":null,"abstract":"Hailey-Hailey Disease, also called Benign Familial Pemphigus, is a genetic acantholytic blistering condition that most commonly affects the intertriginous areas. There are many treatments, both on and off label, for the treatment of this life-long, uncomfortable condition. More efficacious treatments are needed. We believe we are the first to report successful treatment with topical roflumilast, a PDE-4 inhibitor. This helps us to further understand and speculate beyond the genetics, other mechanisms of action that trigger this disease.","PeriodicalId":512642,"journal":{"name":"Journal of Dermatology Research","volume":"123 19","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Case Report of Hailey-Hailey Disease Successfully Treated with Topical Roflumilast 0.3% Cream\",\"authors\":\"Klepper Em\",\"doi\":\"10.46889/jdr.2024.5103\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Hailey-Hailey Disease, also called Benign Familial Pemphigus, is a genetic acantholytic blistering condition that most commonly affects the intertriginous areas. There are many treatments, both on and off label, for the treatment of this life-long, uncomfortable condition. More efficacious treatments are needed. We believe we are the first to report successful treatment with topical roflumilast, a PDE-4 inhibitor. This helps us to further understand and speculate beyond the genetics, other mechanisms of action that trigger this disease.\",\"PeriodicalId\":512642,\"journal\":{\"name\":\"Journal of Dermatology Research\",\"volume\":\"123 19\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Dermatology Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.46889/jdr.2024.5103\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Dermatology Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46889/jdr.2024.5103","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Case Report of Hailey-Hailey Disease Successfully Treated with Topical Roflumilast 0.3% Cream
Hailey-Hailey Disease, also called Benign Familial Pemphigus, is a genetic acantholytic blistering condition that most commonly affects the intertriginous areas. There are many treatments, both on and off label, for the treatment of this life-long, uncomfortable condition. More efficacious treatments are needed. We believe we are the first to report successful treatment with topical roflumilast, a PDE-4 inhibitor. This helps us to further understand and speculate beyond the genetics, other mechanisms of action that trigger this disease.